发明申请
- 专利标题： MIR-150 FOR THE TREATMENT OF BLOOD DISORDERS
- 专利标题（中）： MIR-150治疗血液病症
-
申请号： US12363016申请日： 2009-01-30
-
公开(公告)号： US20090202493A1公开(公告)日： 2009-08-13
- 发明人: Jun Lu , Shangqin Guo , Benjamin Ebert , David Scadden , Todd Golub
- 申请人： Jun Lu , Shangqin Guo , Benjamin Ebert , David Scadden , Todd Golub
- 申请人地址： US MA Boston US MA Cambridge US MA Boston
- 专利权人： THE GENERAL HOSPITAL CORPORATION,MASSACHUSETTS INSTITUTE OF TECHNOLOGY,DANA-FARBER CANCER INSTITUTE, INC.
- 当前专利权人： THE GENERAL HOSPITAL CORPORATION,MASSACHUSETTS INSTITUTE OF TECHNOLOGY,DANA-FARBER CANCER INSTITUTE, INC.
- 当前专利权人地址： US MA Boston US MA Cambridge US MA Boston
- 主分类号： A61K48/00
- IPC分类号： A61K48/00 ; A61P7/06 ; A61P7/02
摘要：
The invention provides methods of treating certain blood related disorders, in particular, thrombocytopenia and anemia comprising increasing miR-150 expression or inhibiting miR-150 in progenitor cells respectively.
信息查询
